FDA OKs Merck's OTC Treatment For Overactive Bladder
The Food and Drug Administration announced Friday that it has approved the first over-the-counter treatment for overactive bladder in women, a transdermal patch marketed by Merck, two months after an advisory...To view the full article, register now.
Already a subscriber? Click here to view full article